MK-677

MK-677 (ibutamoren) is an orally active growth hormone secretagogue that mimics the action of ghrelin. It has been studied in human clinical trials for growth hormone deficiency, muscle wasting, and other conditions. It is one of the few secretagogues with published human pharmacokinetic data.

MK-677 (ibutamoren) functions as a potent, orally active, non-peptide selective agonist of the ghrelin receptor, also known as the growth hormone secretagogue receptor (GHS-R1a). Upon binding to GHS-R1a in the hypothalamus and pituitary gland, it mimics the action of the endogenous hormone ghrelin. This activation stimulates the pulsatile secretion of growth hormone (GH) by activating the phospholipase C-inositol triphosphate pathway, which subsequently increases intracellular calcium levels in somatotroph cells. Unlike synthetic growth hormone analogs that provide exogenous GH, MK-677 amplifies the natural amplitude and frequency of endogenous GH pulses, thereby maintaining physiological feedback loops while significantly elevating serum levels of GH and insulin-like growth factor 1 (IGF-1).

The anabolic and anti-catabolic profile of MK-677 is largely mediated through the downstream effects of elevated IGF-1, which is synthesized primarily in the liver in response to increased GH secretion. IGF-1 activates the PI3K/Akt/mTOR signaling pathway, a central regulator of protein synthesis that promotes skeletal muscle hypertrophy and satellite cell proliferation. Simultaneously, the increase in IGF-1 inhibits the expression of E3 ubiquitin ligases—specifically atrogin-1 and MuRF-1—which are the primary drivers of the ubiquitin-proteasome system responsible for protein degradation.

By suppressing these proteolytic pathways, MK-677 creates an environment conducive to positive nitrogen balance and enhanced muscle protein accretion, while exerting negligible activity on androgen receptors, thereby avoiding the enzymatic pathways associated with aromatization or 5-alpha reduction. Beyond its effects on muscle tissue, MK-677 significantly influences whole-body energy partitioning and metabolic homeostasis. The activation of GHS-R1a in adipose tissue and the central nervous system modulates fuel utilization, potentially favoring lipolysis through the upregulation of hormone-sensitive lipase.

Research suggests that the compound may alter glucose metabolism by increasing insulin sensitivity in certain contexts, though it can induce transient fluctuations in fasting blood glucose levels due to the inherent counter-regulatory actions of elevated growth hormone. Furthermore, the sustained signaling through the GHS-R1a axis appears to support collagen synthesis and bone mineral density over long-term exposure by stimulating osteoblast activity and connective tissue remodeling. Pharmacokinetically, MK-677 is characterized by an extended half-life, reported to be approximately 24 hours, allowing for once-daily administration to maintain steady-state serum concentrations.

It is highly bioavailable after oral ingestion and does not require complex ester cleavage to exert its effects, as it is a stable, non-peptide structure. It remains highly selective for the GHS-R1a receptor and exhibits minimal cross-reactivity with other hormone receptors, including those for gonadotropins or mineralocorticoids. This specificity ensures that its physiological impact is directed primarily through the GH-IGF-1 axis, exerting its influence on body composition and metabolic rate through the integrated orchestration of neuroendocrine signaling rather than direct receptor activation within peripheral tissues.

MK-677 is not approved for human use by the FDA or other major regulators. It is not a controlled substance in most jurisdictions but is sold as a research chemical. Marketing for human consumption is not legal.

Because MK-677 is frequently sourced from non-pharmaceutical entities, there is a risk of chemical impurities, mislabeling, or incorrect dosing. Consumers should prioritize products that provide verifiable third-party Certificates of Analysis (COA) utilizing High-Performance Liquid Chromatography (HPLC) for purity and Mass Spectrometry (MS) for identity verification.